Type
1.
Abel L, Alcaïs A, Schurr E, Van Thuc N, Thai VH, Huong NT, et al. Crohn’s disease susceptibility genes are associated with leprosy in the Vietnamese population. The Journal of infectious diseases. 2012;206(11):1763-7.
Type
1.
Scarlata F, Imburgia C, Trizzino M, Titone L. [Leprosy-like cutaneous presentation of Histoplasma capsulatum infection in an African HIV+ patient]. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive. 2012;20(3):211-3.
Type
1.
Lever. A study to assess the feasibility of support by Netherlands Leprosy Relief to the leprosy programme in Delhi State, India. A feasibility study May 7-14, 1999. Amsterdam: Royal Tropical Institute; 1999 p. 19 p.
Type
1.
Denis. A propos de la transmission instrumentale de la lepre. Mortsel: Louis Denis; 1995 p. 55 p.
Type
1.
Leiker DL. Leprosy in questions and answers. Kaduna: Northern Nigeria Ministry of Health Leprosy Service; p. 53 p.
Type
1.
Parke-Davis. Promin and Promizole in tuberculosis and leprosy. Michigan: Parke, Davis & Company;
Type
1.
Teepe. Misikhu Mission Hospital. Verslag van een orienterend bezoek. Den Haag: B.V. Drukkerij Badoux; 1979 p. 21 p.
Type
1.
Girish. Research: role of antioxidant vitamins in immune function in leprosy. Pharmacie Globale: International Journal of Comprehensive Pharmacy [Internet]. 2011;2(8):1-3. Available from: http://pharmacie-globale.info/index.php?option=com_docman&task=doc_download&gid=188&Itemid=41
Type
1.
Raju, Rao. Medical and social concerns of leprosy cured after integration in India. Indian journal of leprosy [Internet]. 2011;83(3):145-55. Available from: http://www.ijl.org.in/Apr-Jun-/3%20-%20MS%20Raju%20et%20al.pdf
Type
1.
Mohite, Durgawale. Evaluation of national leprosy eradication programme in Satara District, Maharashtra. Indian journal of leprosy [Internet]. 2011;83(3):139-43. Available from: http://www.ijl.org.in/apr-jun-2011/3%20-%20PA%20Giri%20(75-80)c.pdf